Biovie is trading 8.44% up at $1.67 in pre-market on September 29, 2026, with no clear company-specific catalyst identified. - The September 28 close was $1.54. - A September 29 Form DEF 14A filing was reported, but available coverage identifies no material announcement tied to the price change. - The broad-market context is mixed, not a clear same-direction driver, leaving the rebound’s cause uncertain.